Insulin resistance and blood pressure.
Insulin resistance, cardiometabolic syndrome, and hypertension are common health problems with significant consequences for individuals and society. The pathogenesis of these disorders is complex and not fully understood. In this article we review the current knowledge about the effects of lifestyle modification and pharmacologic antihypertensive agents on insulin resistance and hypertension.
Addison
Sonya
S
Diabetes and Cardiovascular Center, University of Missouri School of Medicine, D109 HSC Diabetes Center, One Hospital Drive, Harry S. Truman VA Medical Center, Columbia, MO 65212, USA.
Stas
Sameer
S
Hayden
Melvin R
MR
Sowers
James R
JR
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000627:therapeutic use; D004730:Endothelium, Vascular / Q000503:physiopathology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology*; D007249:Inflammation / Q000503:physiopathology; D007333:Insulin Resistance / Q000502:physiology*; D008019:Life Style; D000451:Mineralocorticoid Receptor Antagonists; D009765:Obesity / Q000503:physiopathology; D012084:Renin-Angiotensin System / Q000502:physiology; D000092502:Renin Inhibitors
D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002317:Cardiovascular Agents; D000451:Mineralocorticoid Receptor Antagonists; D000092502:Renin Inhibitors